Valneva SE (LON:0OB3)
3.498
-0.009 (-0.26%)
Dec 19, 2025, 5:13 PM BST
Valneva SE Market Cap
Valneva SE has a market cap or net worth of 536.25 million as of December 19, 2025. Its market cap has increased by 115.26% in one year.
Market Cap
536.25M
Enterprise Value
582.14M
Revenue
157.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.50
Market Cap Chart
Since June 29, 2007, Valneva SE's market cap has increased from 66.74M to 536.25M, an increase of 703.52%. That is a compound annual growth rate of 11.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 536.25M | 84.69% |
| Dec 31, 2024 | 290.35M | -48.92% |
| Dec 29, 2023 | 568.46M | -25.57% |
| Dec 30, 2022 | 763.80M | -64.68% |
| Dec 31, 2021 | 2.16B | 242.35% |
| Dec 31, 2020 | 631.58M | 219.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 212.02B |
| GSK plc | 73.11B |
| Haleon | 33.29B |
| Smith & Nephew | 10.48B |
| Convatec Group | 4.72B |
| Hikma Pharmaceuticals | 3.35B |
| HUTCHMED (China) | 1.71B |
| Genus | 1.71B |